PubRank

Daria O'Reilly

Author PubWeight™ 35.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Calculating utility decrements associated with an adverse event: marginal Tobit and CLAD coefficients should be used with caution. Med Decis Making 2011 1.67
2 Cost-effectiveness analysis of elective endovascular repair compared with open surgical repair of abdominal aortic aneurysms for patients at a high surgical risk: A 1-year patient-level analysis conducted in Ontario, Canada. J Vasc Surg 2008 1.53
3 The effectiveness of integrated health information technologies across the phases of medication management: a systematic review of randomized controlled trials. J Am Med Inform Assoc 2011 1.38
4 Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate? Value Health 2010 1.32
5 Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin 2007 1.23
6 A review of the cost of cardiovascular disease. Can J Cardiol 2009 1.20
7 Validation of Chinese Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) in patients scheduled for total knee replacement. Qual Life Res 2008 1.08
8 Effects of study design and trends for EVAR versus OSR. Vasc Health Risk Manag 2008 0.97
9 Health status, hospitalizations, day procedures, and physician costs associated with body mass index (BMI) levels in Ontario, Canada. Clinicoecon Outcomes Res 2012 0.96
10 Transferability of health technology assessments and economic evaluations: a systematic review of approaches for assessment and application. Clinicoecon Outcomes Res 2011 0.95
11 Safety of tissue expander/implant versus autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients: a systematic review and meta-analysis. Plast Reconstr Surg 2014 0.94
12 Intra-arterial thrombolysis vs. standard treatment or intravenous thrombolysis in adults with acute ischemic stroke: a systematic review and meta-analysis. Int J Stroke 2013 0.94
13 Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents. Clinicoecon Outcomes Res 2012 0.92
14 A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment. Pharmacoeconomics 2010 0.92
15 Enabling medication management through health information technology (Health IT). Evid Rep Technol Assess (Full Rep) 2011 0.92
16 A cost-effectiveness model comparing endovascular repair to open surgical repair of abdominal aortic aneurysms in Canada. Value Health 2008 0.88
17 Total or partial knee replacement? Cost-utility analysis in patients with knee osteoarthritis based on a 2-year observational study. Eur J Health Econ 2009 0.88
18 E-health interventions as complex interventions: improving the quality of methods of assessment. AMIA Annu Symp Proc 2006 0.88
19 Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada. Cost Eff Resour Alloc 2010 0.88
20 A review of health utilities across conditions common in paediatric and adult populations. Health Qual Life Outcomes 2010 0.88
21 Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada. J Am Coll Radiol 2009 0.86
22 Universal or targeted screening for fetal alcohol exposure: a cost-effectiveness analysis. J Stud Alcohol Drugs 2008 0.82
23 Canadian cost- utility analysis of intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura. J Popul Ther Clin Pharmacol 2012 0.82
24 Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease. J Crohns Colitis 2011 0.81
25 Should endovascular repair be reimbursed for low risk abdominal aortic aneurysm patients? Evidence from ontario, Canada. Int J Vasc Med 2011 0.81
26 Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative study. J Popul Ther Clin Pharmacol 2015 0.80
27 Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective. Expert Rev Pharmacoecon Outcomes Res 2011 0.79
28 General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals. Expert Rev Pharmacoecon Outcomes Res 2010 0.79
29 Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences. Expert Rev Pharmacoecon Outcomes Res 2013 0.78
30 Cost-effectiveness of reducing wait times for cataract surgery in Ontario. Can J Ophthalmol 2008 0.78
31 Cost-effectiveness of catheter ablation for rhythm control of atrial fibrillation. Int J Vasc Med 2013 0.78
32 Prehospital evaluation and economic analysis of different coronary syndrome treatment strategies--PREDICT--rationale, development and implementation. BMC Emerg Med 2011 0.78
33 Do different decision-analytic modeling approaches produce different results? A systematic review of cross-validation studies. Expert Rev Pharmacoecon Outcomes Res 2015 0.78
34 Conditionally funded field evaluations and practical trial design within a health technology assessment framework. J Am Coll Radiol 2009 0.78
35 Economic evaluations conducted by Canadian health technology assessment agencies: where do we stand? Int J Technol Assess Health Care 2008 0.77
36 Health technology assessment and primary data collection for reducing uncertainty in decision making. J Am Coll Radiol 2009 0.77
37 Effect of computer-generated tailored feedback on glycemic control in people with diabetes in the community: a randomized controlled trial. Diabetes Care 2011 0.76
38 Quality of medical care during and shortly after acute care restructuring in Newfoundland and Labrador. J Health Serv Res Policy 2005 0.76
39 Impact of the 1997 Canadian guidelines on the conduct of Canadian-based economic evaluations in the published literature. Value Health 2009 0.76
40 Technology resource planning in radiation oncology: application of a needs-based analytic framework to radiosurgery planning in Ontario. J Oncol Pract 2012 0.75
41 Managing multiple projects: a literature review of setting priorities and a pilot survey of healthcare researchers in an academic setting. Perspect Health Inf Manag 2007 0.75
42 Conditionally funded field evaluations: PATHs coverage with evidence development program for Ontario. Value Health 2010 0.75
43 Health technology assessment for radiologists: basic principles and evaluation framework. J Am Coll Radiol 2009 0.75
44 In search of the evidentiary foundation of published Canadian economic evaluations (2001-06). Int J Technol Assess Health Care 2009 0.75
45 Long-term care in the St. John's region: impact of single entry and prediction of bed need. Healthc Manage Forum 2005 0.75
46 Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in Ontario. Expert Rev Pharmacoecon Outcomes Res 2013 0.75